Legal Representation
Attorney
Scot A. Duvall
USPTO Deadlines
Next Deadline
1051 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-27)
Due Date
September 27, 2028
Grace Period Ends
March 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 22, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Feb 7, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jan 18, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jan 18, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 27, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Sep 27, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 27, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 18, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 12, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 12, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 29, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jun 29, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jun 22, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 6, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 6, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 6, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 6, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 6, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 3, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 3, 2022 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| May 25, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 24, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 24, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 6, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jan 18, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 18, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Dec 28, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 27, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 22, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 27, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 22, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Vaccines; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of HIV/AIDS; pharmaceutical preparations for the prevention and treatment of liver diseases; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; drugs for medical purposes for the prevention and treatment of HIV/AIDS; drugs for medical purposes for the prevention and treatment of liver diseases; drugs for medical purposes for the prevention and treatment of respiratory system disorders; drugs for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; drugs for medical purposes for the prevention and treatment of gastro-intestinal diseases; drugs for medical purposes for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; biological preparations for medical purposes for the prevention and treatment of HIV/AIDS; biological preparations for medical purposes for the prevention and treatment of liver diseases; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; medicines for human purposes for the prevention and treatment of HIV/ AIDS; medicines for human purposes for the prevention and treatment of liver diseases; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; chemico-pharmaceutical preparations for the treatment of viral and infectious diseases, immune system related diseases, cancer, tumors and inflammation; chemical preparations for pharmaceutical purposes for the treatment of viral and infectious diseases, immune system related diseases, cancer, tumors and inflammation
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Biological research; research and development of new products for others; scientific laboratory services; scientific research; chemical analysis; conducting clinical trials for others; technological research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical scientific feasibility project studies; chemistry services, namely, consultation, research and advice; chemical research
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
035
042